Clinical Trials Directory

Trials / Unknown

UnknownNCT01514253

Reduced Infant Response to a Routine Care Procedure After Glucose 25% Analgesia in Comparison to Materna RTF Stage 1

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
The Baruch Padeh Medical Center, Poriya · Other Government
Sex
All
Age
1 Day – 16 Days
Healthy volunteers
Accepted

Summary

Glucose has analgesic and calming effects in newborns. To date, it is not known whether the beneficial effects extend to care giving procedures that are performed after painful procedures. The investigators objective is to determine the effect of glucose 25% analgesia in comparison to Materna RTF Stage 1 for procedural pain on infant pain responses during a subsequent care giving procedure.

Detailed description

During hospitalization, a neonate undergoes a number of necessary procedures that may be either painful or cause discomfort to the baby. Pain experienced during the neonatal period is known to have long term effects on the baby. The red-reflex test is a routine examination performed on a neonate after birth and once again before discharge from the hospital. The examination causes discomfort to the infant Glucose has analgesic and calming effects in newborns. To date, it is not known whether the beneficial effects extend to care giving procedures that are performed after painful procedures. The investigators objective is to determine the effect of glucose 25% analgesia in comparison to Materna RTF Stage 1 for procedural pain on infant pain responses during a subsequent care giving procedure.

Conditions

Interventions

TypeNameDescription
DRUGGlucose 25%1 ml glucose 25%, once
DIETARY_SUPPLEMENTMaterna RTF Stage 11ml Materna RTF Phase 1, 2-3 minutes prior red-reflex examination.
OTHERWater for Injection1 ml Water for Injection (WFI), 2-3 minutes prior red-reflex examination

Timeline

Start date
2012-02-01
Primary completion
2012-05-01
Completion
2012-07-01
First posted
2012-01-23
Last updated
2012-01-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01514253. Inclusion in this directory is not an endorsement.